This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
N. W. Barton , F. S Furbish , G. I. Murray , M. Garfield , and R. O. Brady . 1990. “Therapeutic Response to Intravenous Infusions of Glucocerebrosidase in a Patient with Gaucher Disease.” Proceedings of National Academy of Science USA 87:1913–16.
E. Beutler and T. Gelbart . 1996. “Glucocerebrosidase (Gaucher disease).” Human Mutation 8:207–13.
E. Broide , M. Zeigler , J. Ecksetin , and G. Bach . 1993. “Screening for Carriers of Tay-Sachs Disease in the Ultraorthodox Ashkenazi Jewish Community in Israel.” American Journal of Medical Genetics 47:213–15.
R. T. Croyle , J. S. Achilles , and C. Lerman . 1997. “Psychologic Aspects of Cancer Genetic Testing.” Cancer 80:569–75.
D. Easton 1997. “Breast Cancer Genes — What Are the Real Risks?” Nature Genetics 16:210–11.
S. A. Gayther , and B. A. J. Ponder . 1997. “Mutations of the BRC1 and BRC2 Genes and the Possibilities for Predictive Testing.” Molecular Medicine Today 3:168–74.
M. Kaufman , J. Grinshpun Cohen , M. Karpati , L. Peleg , B. Goldman , E. Akstein , A. Adam , and R. Navon . 1997. “Tay-Sachs Disease and HAXA Mutations among Moroccan Jews.” Human Mutation 10:295–300.
E. Kerem , Y. M. Kalman , Y. Yahav , T. Shoshani , D. Abeliovich , A. Szeinberg , J. Rivlin , H. Blau , A. Tal , L. Ben-Tur , C. Springer , A. Augarten , S. Godfrey , I. Lerer , D. Branski , M. Friedman , and B. Kerem . 1995. “Highly Variable Incidence of Cystic Fibrosis and Different Mutation Distribution among Different Jewish Ethnic Groups in Israel.” Human Genetics 96:193–97.
C. Lerman , M. Daly , C. Sands , A. Balshem , E. Lustbader , T. Heggan , L. Goldstein , J. James , and P. Engstrom . 1993. “Mammography Adherence and Psychological Distress among Women at Risk for Breast Cancer.” Journal of National Cancer Institute 85:1074–80.
Y. Miki , J. Swensen , D. Slattuck-Gidens , P. A. Futreal , K. Harshman , K. Tavtigian , and A. Lui . 1994. “A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRC1.” Science 266:66–71.
B. Modell , and A. M. Kuliev . 1991. “Services for Thalassaemia as a Model for Cost Benefit Analysis of Genetic Services.” Journal of Inherited Metabolic Diseases 14:640–51.
B. Newman , M. A. Austim , M. Lee , and M.-C. King . 1988. “Inheritance of Human Breast Cancer: Evidence for Autosomal Dominant Transmission in High-Risk Families.” Proceedings of the National Academy of Science USA 85:3044–48.
B. B. Roa , A. A. Boyd , K. Volcik , and C. S. Richards . 1996. “Ashkenazi Jewish Population Frequencies for Common Mutations in BRC1 and BRC2.” Nature Genetics 14:185–87.
M. Sagi , S. Shiloh , and T. Cohen . 1992. “Application of the Health Belief Model in a Study on Parents' Intentions to Utilize Prenatal Diagnosis of Cleft Lip and/or Palate.” American Journal of Medical Genetics 44:326–33.
S. Shiloh 1996. “Genetic Counseling: A Developing Area of Interest for Psychologists.” Professional Psychology: Research and Practice 27:475–86.
J. P. Struewing , P. Hartge , S. Wacholder , S. M. Baker , M. Berlin , M. McAdams , M. M. Timmerman , L. C. Brody , and M. A. Tucker . 1997. “The Risk of Cancer Associated with Specific Mutations of BRCI and BRC2 among Ashkenazi Jews.” New England Journal of Medical Genetics 336:1401–08.
R. Wooster , G. Bignell , J. Lancaster , S. Swift , S. Seal , J. Mangion , N. Collins , S. Gregory , C. Gumbs , and G. Micklem . 1995. “Identification of the Breast Susceptibility gene BRC2.” Nature 378:789–92.
A. Zimran , A. Kay , T. Gelbart , P. Garver , D. Thurston , A. Saven , and E. Beutler . 1992. “Gaucher Disease: Clinical, Laboratory, Radiologic and Genetic Features in 53 Patients.” Medicine 71:337–53.